Study on Mechanism of Awei Bawei Pill in treating Meniere's Syndrome based on network pharmacology

  • ZHANG Shuning ,
  • AN Ming ,
  • BO Yukun ,
  • GUO Meitong ,
  • YANG Dan
Expand
  • Baotou Medical College, Inner Mongolia University of Science and Technology, Baotou 014040,China

Received date: 2023-06-30

  Online published: 2024-05-20

Abstract

Objective: To explore the mechanism of treating Meniere's syndrome with Awei Bawei Pill, a Mongolian medicine preparation, based on network pharmacology and molecular docking technology, and provide systematic biological information and theoretical basis for treating Meniere's syndrome with Chinese and Mongolian medicines. Methods: The active ingredients of Awei-8 Pill were discovered by searching the TCMSP, BATMAN-TCM and SwissTargetPrediction databases and reviewing the literature; GeneCards, OMIM and DrugBank databases were used to obtain the related targets of Meniere's syndrome, and the drug-disease targets were mapped to obtain the intersection targets; the PPI network was constructed by STRING network platform and the core genes were screened by Cytoscape 3.9.1 software. STRING network platform to construct PPI network and use Cytoscape 3.9.1 software to screen out core genes; DAVID data platform was used for GO enrichment analysis and KEGG enrichment analysis; finally, the key active ingredients and core targets obtained were validated and analyzed by molecular docking technology. Results: 37 active ingredients, 521 predicted action targets, 695 genes related to Meniere's syndrome, and 15 key targets for the treatment of Meniere's syndrome with A. ferrugineum were obtained; a total of 9 key active ingredients and 5 core targets for the treatment of Meniere's syndrome with A. ferrugineum were screened;GO enrichment analysis showed the first five items of cell component (CC), molecular function (MF) and biological process (BP), KEGG pathway enrichment yielded 20 major pathways; molecular docking showed that the key active ingredients had good binding ability to the core targets. Conclusions: Awei Bawei Pill can play a synergistic role in treating Meniere's syndrome through multi-component, multi-target and multi-channel mechanism.

Cite this article

ZHANG Shuning , AN Ming , BO Yukun , GUO Meitong , YANG Dan . Study on Mechanism of Awei Bawei Pill in treating Meniere's Syndrome based on network pharmacology[J]. Journal of Baotou Medical College, 2024 , 40(5) : 79 -85 . DOI: 10.16833/j.cnki.jbmc.2024.05.015

References

[1] 刘淑琴. 黑云香挥发油化学成分GC/MS分析[J].内蒙古民族大学学报(自然科学版), 2011, 26(5): 515-517.
[2] 李卫平.盐酸氟桂利嗪治疗美尼尔氏综合征的临床疗效[J]. 临床合理用药杂志,2018, 11(9): 67-68.
[3] 杨丹, 李刚, 郭叶, 等.HPLC法同时测定蒙成药阿魏八味丸中5种化学成分的含量[J]. 沈阳药科大学学报, 2021, 38(5): 472-478.
[4] 白龙, 韩玉华. 阿魏八味丸为主治疗美尼尔氏综合症80例[J]. 中国民族医药杂志, 2008, 14(6): 14.
[5] 包玉秋, 王青虎. 蒙成药阿魏八味丸的质量标准研究[J]. 内蒙古民族大学学报(自然科学版), 2011, 26(5): 555-560.
[6] 蒋佳敏, 陈荣玲, 牛圣皓, 等.基于网络药理学和分子对接探讨莳萝子油脂抗肿瘤的生物活性[J]. 广东化工, 2023, 50(9): 56-59
[7] 马晶莹, 张雷雷, 马旺然, 等. 槲皮素治疗帕金森病作用机制的研究现状[J]. 中国临床药理学杂志, 2022, 38(23): 2919-2923.
[8] 韦子强, 张雯雯, 郭嘉亮, 等. 阿魏酸抑制p38 MAPK信号传导对巨噬细胞M1极化的作用[J].广东药科大学学报, 2023, 39(3): 68-72.
[9] 许英, 陈玲, 张兰, 等.阿魏酸通过调节GSK-3β减轻阿尔茨海默样变化[J]. 中南药学, 2022, 20(4): 805-811.
[10] 李思慧, 姜岩, 刘光宇, 等. 胆碱能受体对海马区LTP的影响[J]. 内蒙古民族大学学报, 2009, 15(5): 33-34.
[11] 张万萍, 余永游. 单胺氧化酶抑制药物神经保护作用的研究进展[J]. 山东化工, 2015, 44(1): 62-64.
[12] 张慧敏, 向科发, 史小飞, 等.胆碱能抗炎通路α7烟碱型乙酰胆碱受体的最新研究进展[J]. 药学实践与服务, 2022, 40(6): 485-493.
Outlines

/